Ann M. Daus

Corporate Officer/Principal at Laureate Biopharmaceutical Services, Inc.

Consumer Services

Health Technology

Profile

Ann M.
Daus is currently the Vice President-Quality at Laureate Biopharmaceutical Services, Inc. She has a graduate and doctorate degree from Rutgers State University of New Jersey and an undergraduate degree from Millersville University.

Ann M. Daus active positions

Companies	Position	Start
Laureate Biopharmaceutical Services, Inc. Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ.	Corporate Officer/Principal	2011-03-15

All active positions of Ann M. Daus

Training of Ann M. Daus

Millersville University	Undergraduate Degree
Rutgers State University of New Jersey	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ann M. Daus's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Laureate Biopharmaceutical Services, Inc. Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ.	Health Technology